Cargando…

High expression of CHML predicts poor prognosis of multiple myeloma

Multiple myeloma is a hematological tumor with a malignant proliferation of myeloma cells. Although the survival time after treatment has improved, the recurrence rate of MM is still high. Choroideremia-like (CHML) protein is essential for the prenylation modification of various Rab proteins and it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Weilong, Cao, Ling, Liu, Xiaoni, He, Xue, Zhang, Ye, Yang, Zuozhen, Yang, Ping, Wang, Jing, Hu, Kai, Zhang, Xiuru, Liu, Weiyou, Yuan, Xiaoliang, Jing, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856588/ https://www.ncbi.nlm.nih.gov/pubmed/31762814 http://dx.doi.org/10.7150/jca.34465

Ejemplares similares

High expression of UBE2T predicts poor prognosis and survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Prognosis value of RBBP8 expression in plasma cell myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Clinical prognostic implications of EPB41L4A expression in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2020)

Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2018)

High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia
por: Song, Ying, et al.
Publicado: (2019)

The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia
por: Cao, Ling, et al.
Publicado: (2019)

Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia
por: Lai, Rui, et al.
Publicado: (2020)

CHML promotes liver cancer metastasis by facilitating Rab14 recycle
por: Chen, Tian-Wei, et al.
Publicado: (2019)

CHML is an NRF2 target gene that regulates mTOR function
por: Dodson, Matthew, et al.
Publicado: (2022)

Dysregulation of N(6)-methyladenosine regulators predicts poor patient survival in mantle cell lymphoma
por: Zhang, Weilong, et al.
Publicado: (2019)

Exosome complex genes mediate RNA degradation and predict survival in mantle cell lymphoma
por: Zhang, Weilong, et al.
Publicado: (2019)

Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
por: Liu, Xuewen, et al.
Publicado: (2017)

Increased Expression of SRSF1 Predicts Poor Prognosis in Multiple Myeloma
por: Zhang, Jiawei, et al.
Publicado: (2023)

Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma
por: Xiang, Jing, et al.
Publicado: (2022)

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma
por: Zheng, Dong, et al.
Publicado: (2022)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017)

S1PR2 Knockdown Promotes Migration and Invasion in Multiple Myeloma Cells via NF-κB Activation
por: Pang, Meng, et al.
Publicado: (2020)

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
por: Barwick, Benjamin G., et al.
Publicado: (2019)

High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma
por: Zhang, Hailing, et al.
Publicado: (2022)

Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma
por: Qiu, Chen, et al.
Publicado: (2021)

IgA Type Multiple Myeloma, Clinical Features, and Prognosis
por: Wang, Ling, et al.
Publicado: (2018)

ARNT/HIF‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
por: Wu, Chuan, et al.
Publicado: (2018)

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
por: Walker, Brian A, et al.
Publicado: (2015)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
por: Noll, Jacqueline E., et al.
Publicado: (2015)

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma
por: Ebert, Lisa M., et al.
Publicado: (2021)

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
por: He, JingSong, et al.
Publicado: (2021)

PB2079: LACTATE DECREASES BORTEZOMIB SENSITIVITY AND PREDICTS POOR CLINICAL OUTCOMES OF MULTIPLE MYELOMA
por: MA, Naya, et al.
Publicado: (2023)

FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2023)

PB2080: LOW DUP1 EXPRESSION PREDICTS POOR PROGNOSIS IN MULTIPLE MYELOMA
por: Lu, Jinfeng, et al.
Publicado: (2023)

High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer
por: Li, Yang, et al.
Publicado: (2020)

Joint effect of THBS2 and VCAN accelerating the poor prognosis of gastric cancer
por: Wang, Long, et al.
Publicado: (2023)

Clinical characteristics and prognosis of multiple myeloma with bone-related extramedullary disease at diagnosis
por: Tian, Chen, et al.
Publicado: (2018)

BMI1 regulates multiple myeloma-associated macrophage’s pro-myeloma functions
por: Zhang, Danfeng, et al.
Publicado: (2021)

High expression of GMNN predicts malignant progression and poor prognosis in ACC
por: Zhao, Xinzhao, et al.
Publicado: (2022)

Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells
por: Geng, Yan, et al.
Publicado: (2018)

Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma
por: Kim, Miyoung, et al.
Publicado: (2016)

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
por: Pawlyn, C, et al.
Publicado: (2017)

The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lrk42thag2103t6tbdsm0mt91v